Biogen Inc (BIIB.O)
27 May 2016
The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc, with a boxed warning.
May 27 The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc, with a boxed warning.
* Regenxbio and Biogen enter exclusive license agreement for the development of gene therapy treatments for rare genetic vision disorders
Biogen Inc plans to spin off its hemophilia drug business as a publicly traded company, leaving the drugmaker to focus on developing drugs for neurodegenerative diseases, the company said on Tuesday.
* Biogen announces intent to spin off its hemophilia business
* Biogen and abbvie receive positive opinion from the chmp on zinbryta(tm) (daclizumab) for treatment of multiple sclerosis
* Biogen appoints Michael Ehlers executive vice president, research and development Source text for Eikon: Further company coverage:
* CEO, asked about interest in Biogen's hemophilia assets, says "this is not a time to bet the company on something that is at the outer limits of our capacity"
Aggressive cost cutting propelled Biogen Inc to a better-than-expected first quarter profit as the biotechnology company's reorganization moves began to pay off, and its shares rose nearly 5 percent.
* 1st-qtr profit $4.79/shr vs est. $4.47 (Adds company, analyst comment, share move)
|Johnson & Johnson (JNJ.N)||$113.06||+0.16|
|Pfizer Inc. (PFE.N)||$34.61||+0.18|
|Novartis AG (NOVN.S)||CHF79.55||-0.05|
|Merck & Co., Inc. (MRK.N)||$56.48||+0.09|
|Roche Holding Ltd. (ROG.S)||CHF262.00||-1.40|
|Roche Holding Ltd. (RO.S)||CHF262.25||-1.50|
|Bayer AG (BAYGn.DE)||€86.44||+1.11|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€73.91||+0.11|
|GlaxoSmithKline plc (GSK.L)||1,452.50p||-4.50|
Earnings vs. Estimates
Analyst Research Reports
Provider : Thomson Reuters Stock Report
Provider : New Constructs, LLC
Trading Report for (BIIB). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : ValuEngine, Inc.
Provider : S&P Capital IQ – STARS Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.